Cencora, Inc. (COR) — Fair Value Analysis
Base-case fair value (P50): $245.65 · Current price: $257.71 · Verdict: Fairly Valued
The Verdict on COR
Our Monte Carlo simulations indicate Cencora (COR), a major player in the Healthcare sector, is Fairly Valued at its current market price. With a current price of $253.91, COR's median fair value (P50) is calculated at $254.04, representing a negligible +0.1% difference. This tight alignment suggests that the market price closely reflects the intrinsic value derived from thousands of forward-looking scenarios. The simulations suggest minimal immediate upside or downside from current levels, positioning COR squarely within its fair valuation range based on current fundamentals and market conditions.
How COR stacks up against Healthcare
Cencora's operational and financial health is categorized as an average quality tier relative to its Healthcare sector peers. This assessment, combined with the Monte Carlo simulation's Fairly Valued verdict, underscores a balanced risk-reward profile for COR. Despite being an average quality tier company within the Healthcare space, the quantitative models show the market is efficiently pricing COR near its calculated median fair value of $254.04, which is just +0.1% above its current price of $253.91. This average quality status does not deter the model from finding the current price to be appropriately reflective of its underlying value.
What this means for investors
Given Cencora's Fairly Valued assessment and a median fair value of $254.04 standing only +0.1% above its current price of $253.91, investors should consider that the stock is trading efficiently. The tight convergence of the current price with the Monte Carlo P50 suggests that short-term directional moves based purely on valuation may be limited. While a downside scenario or bull case exists, the Fairly Valued verdict implies that the stock's intrinsic value is largely captured. Sign up for FairCurve to see the full bear/bull distribution and track COR's fair value as new fundamentals are released.
Frequently Asked Questions
Is COR overvalued or undervalued right now?
Based on Monte Carlo simulations, COR is Fairly Valued. The median fair value (P50) of $254.04 is only +0.1% above its current price of $253.91, indicating efficient pricing.
What is the bear case and bull case for COR?
The full Monte Carlo distribution, including bear (P10) and bull (P90) targets, plus the probability of upside, is available with a free FairCurve account. Specific dollar values for these scenarios are not publicly disclosed.
How does FairCurve calculate COR's fair value?
FairCurve calculates COR's fair value by running Monte Carlo simulations over thousands of forward scenarios, modeling various financial outcomes to determine a robust intrinsic valuation.
How can I track COR's fair value as it changes?
You can add COR to a free FairCurve watchlist for daily fair-value updates and instant re-valuation when new earnings or significant fundamental data are released.